Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Mr. Andy Watson joins RainDance from Life Technologies where he was most recently Vice President, SOLiD Sequencing Product Management responsible for business strategy, market analysis, and product management for all sequencing-by-ligation and single-molecule DNA sequencing systems.
Previously, he led Applied Biosystems' (now part of Life
Technologies) capillary electrophoresis (CE) sequencing business. At Applied Biosystems, he also led a number of genetic analysis market and strategy projects that culminated in the acquisition of the SOLiD sequencing technology.
Before joining Applied Biosystems, Mr. Watson was a founder of Quantum Dot Corporation (acquired by Invitrogen). He also led the development of technologies and software for large scale DNA analysis at Sequana Therapeutics (acquired by Celera) and at The Sanger Centre. Mr. Watson has been the principal investigator on competitive federal grants and is an inventor on more than 25 issued patents and applications.
He holds M.Eng., M.A., and B.A. degrees from King's College, Cambridge University, England.